Mundipharma
Etienne Claessens is a seasoned HR executive with extensive experience in leadership roles across various multinational companies. Currently serving as Chief People Officer at Mundipharma since November 2023, Claessens previously held the position of Vice President, Human Resources EMEA at Baxter International Inc. from December 2021 to November 2023. Prior roles include Vice President, Human Resources EMEA and BU Surgical Solutions at Hillrom, as well as Vice President, Human Resources International for the company. Claessens has also contributed significantly to Philips and its subsidiaries, occupying roles such as Vice President, Human Resources and Senior Director Human Resources. Educational qualifications include a Master's degree in Management and Organizational Sciences from Tilburg University and additional studies at London Business School and the University of Michigan - Stephen M. Ross School of Business.
This person is not in any teams
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.